Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer

Journal of Laryngology and Otology

Volumn 123, Issue 2, 2009, Pages 223-228

  Rashad, U M ^a,c   Al Gezawy, S M ^a   El Gezawy, E ^a   Azzaz, A N ^b  

^a Assiut University Faculty of Medicine   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Head and Neck Neoplasms; Honey; Mucositis; Radiotherapy

Indexed keywords

CISPLATIN; HEMOGLOBIN; SEROTONIN ANTAGONIST; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AEROBIC BACTERIUM; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EGYPT; FEMALE; HEAD AND NECK CANCER; HEMOGLOBIN BLOOD LEVEL; HONEY; HUMAN; HYDRATION; LEUKOCYTE COUNT; MALE; MUCOSA INFLAMMATION; OROPHARYNX; PROPHYLAXIS; RADIATION DOSE; RADIOCHEMOTHERAPY INDUCED MUCOSITIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT; VOMITING; HEAD AND NECK TUMOR; MICROBIOLOGY; MIDDLE AGED; MOUTH MUCOSA; MULTIMODALITY CANCER THERAPY; RADIATION EXPOSURE; RADIATION INJURY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HONEY; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOSITIS; RADIATION INJURIES; TREATMENT OUTCOME;

EID: 65249131719     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215108002478     Document Type: Article

References (23)

1. Stokman MA, Spijkervet FK, Burlage FR. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind ran domised clinical trial. Br J Cancer2003;88:1012-16
2. Al-Tikriti U, Martin MV, Bramley PA. A pilot study of the clinical effects of irradiation on the oral tissues. Br J Oral Maxillofac Surg 1984;22:77-86
3. Bernhoft CH, Skaug N. Oral findings in irradiated edentulous patients. Int J Oral Surg 1985;14:416-27
4. Sonis ST. A biological approach to mucositis. J Support Oncol 2004;2:21-2
5. Demarosi F, Bez C, Carrassi A. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.Minerva Stomatol 2002;51:173- 86
6. DeVries A, Sprinzl G, Reich K, Gunczler P, Thumfart W,Lukas P. GM-CSF-mouth wash for treatment of chemotherapy patients with advanced head and neck cancer a clinical trial. Ann Oncol 2001;11(suppl 4):409PD
7. Hanson WR, Marks JE, Reddy SP. Protection from radiation induced oral mucositis by a mouth rinse containing prostaglandin E analogue, misoprostol: a placebo controlled double blind clinical trial. Adv Exp Med Biol1997;400B:811-18
8. Leborgne JH, Leborgne F, Zubizarreta E, Ortega B,Mezzera J. Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomised trial. Radiother Oncol 1997;47:145 -8
9. Tannehill SP, Mehta MP. Amifostine and radiation therapy: past, present and future. Semin Oncol 1996;23(suppl 8):69-77
10. Zumla A, Lulat A. Honey - a remedy rediscovered. JRSoc Med 1989;82:384-5
11. Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003;11:242-8
12. Molan PC. The potential of honey to promote oral well-ness. Gen Dent 2001;49:584-9
13. Bergman A, Yanai J, Weiss J, Bell D, David MP. Acceleration of wound healing by topical application of honey. Am J Surg 1983;145:374-6
14. Cooper RA, Molan PC, Harding KG. Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J Roy Soc Med 1999;92:283-5
15. Sela MO, Shapira L, Grizim I. Effects of honey consumption on enamel microhardness in normal versus xerostomic patients. J Oral Rehabil 1998;25:630-4
16. Karnofsky D, Abelman W, Craver L, Burchenal J. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56
17. El-Sayed S, Nabid A, Shelley W. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 2002;20:3956-63
18. World Health Organization. WHO Handbook for Reporting the Results ofCancer Treatment. Geneva: WHO Offset Publications, 1979
19. Rahn R, Adamietz IA, Boettcher HD. Povidone-iodine to prevent mucositis in patients during antineoplastic radio chemotherapy. Dermatology 1997;195(suppl2):57-61
20. Matthews RH, Ercal N. Prevention of mucositis in irradiated head and neck cancer patients. J Exp Ther Oncol1996;1:135-8
21. Koc M, Aktas E. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers. Japanese Journal of Clinical Oncology 2003;33:57-60
22. Spijkervet FK, Van Saene HK, Van Saene JJ, Panders AK,Vermey A, Mehta DM et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991;46:167 -73
23. Mucke R, Kaben U, Libera T, Knauerhase H, Ziegler PG,Hamann D et al. Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors. Mycoses 1997;40(suppl 1):53-5